Berylliosis
Berylliosis | |
---|---|
Specialty | Pulmonology |
Berylliosis, or chronic beryllium disease (CBD), is an occupational lung disease that is most classically associated with exposure to fluorescent lighting and missile silos. It is a chronic allergic-type lung response and chronic lung disease caused by exposure to beryllium and its compounds. The condition is incurable, but symptoms can be treated.[1]
Symptoms
With single or prolonged exposure by inhalation, the lungs become hypersensitive to beryllium causing the development of small inflammatory nodules, called granulomas.
Granulomas are seen in other chronic diseases, such as tuberculosis, sarcoidosis, and it can occasionally be hard to distinguish berylliosis from these disorders.
Ultimately, this process leads to restrictive lung disease, a decreased diffusion capacity.
Clinically patients experience cough and shortness of breath. Other symptoms include chest pain, joint aches, weight loss and fever.
Rarely, one can get granulomas in other organs including the liver.
The onset of symptoms can range from weeks up to tens of years from the initial exposure. In some individuals a single exposure can cause berylliosis.
References
- ^ Naeye RL (1973). "Immunologic aspects of chronic berylliosis". Chest. 63 (3): 306–7. doi:10.1378/chest.63.3.306. PMID 4540228.
{{cite journal}}
: Unknown parameter|month=
ignored (help)
External links
- ATSDR Case Studies in Environmental Medicine: Beryllium Toxicity U.S. Department of Health and Human Services
- About.com
- Health-cares.net
- Instant insight from the Royal Society of Chemistry examining the molecular basis of chronic beryllium disease